Taking advantage of recent successes, Roche will push obesity drugs faster, flirts with M&A
With GLP-1 drugs taking the pharma world by storm, Roche is attempting to push forward the drugs it acquired in its Carmot Therapeutics acquisition last …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
